Elderly oftentimes have the lowest SVP rates compared to age groups. There is a way to boost this percentage as a recent DAA therapy study has shown that it benefits the elderly w/ HCV genotype 1b similarly to younger patients.
Elderly oftentimes have the lowest SVP rates compared to age groups. There is a way to boost this percentage as a recent DAA therapy study has shown that it benefits the elderly w/ HCV genotype 1b similarly to younger patients.